PE20220767A1 - Derivados heterociclicos condensados - Google Patents

Derivados heterociclicos condensados

Info

Publication number
PE20220767A1
PE20220767A1 PE2021001959A PE2021001959A PE20220767A1 PE 20220767 A1 PE20220767 A1 PE 20220767A1 PE 2021001959 A PE2021001959 A PE 2021001959A PE 2021001959 A PE2021001959 A PE 2021001959A PE 20220767 A1 PE20220767 A1 PE 20220767A1
Authority
PE
Peru
Prior art keywords
compounds
heterocyclic condensed
condensed derivatives
derivatives
preparing
Prior art date
Application number
PE2021001959A
Other languages
English (en)
Inventor
Sandrine Celine Grosse
Lindsey Graham Deratt
Koen Vandyck
Pierre Jean-Marie Bernard Raboisson
Serge Maria Aloysius Pieters
Bart Rudolf Romanie Kesteleyn
Wim Gaston Verschueren
Jan Martin Berke
Morgan Charles R Lecomte
Lamenca Carolina Martinez
Tim Hugo Maria Jonckers
Gang Deng
Yimin Jiang
Yanping Xu
Zhanling Cheng
Lili Hu
Scott D Kuduk
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of PE20220767A1 publication Critical patent/PE20220767A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La solicitud describe compuestos de derivado heterociclo condensado, composiciones farmaceuticas que comprenden estos compuestos, procedimientos quimicos para preparar estos compuestos y su uso en el tratamiento de enfermedades asociadas con infeccion por VHB.
PE2021001959A 2019-05-28 2020-05-27 Derivados heterociclicos condensados PE20220767A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962853533P 2019-05-28 2019-05-28
EP19176933 2019-05-28
CN2020085720 2020-04-20
PCT/US2020/034643 WO2020243135A1 (en) 2019-05-28 2020-05-27 Fused heterocyclic derivatives

Publications (1)

Publication Number Publication Date
PE20220767A1 true PE20220767A1 (es) 2022-05-16

Family

ID=71741889

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2021001959A PE20220767A1 (es) 2019-05-28 2020-05-27 Derivados heterociclicos condensados

Country Status (17)

Country Link
EP (1) EP3976617A1 (es)
JP (1) JP2022535734A (es)
KR (1) KR20220012913A (es)
CN (1) CN113906028A (es)
AU (1) AU2020285718A1 (es)
BR (1) BR112021022889A8 (es)
CA (1) CA3138168A1 (es)
CL (1) CL2021003155A1 (es)
CO (1) CO2021016433A2 (es)
CR (1) CR20210666A (es)
IL (1) IL288322A (es)
JO (1) JOP20210313A1 (es)
MA (1) MA56043A (es)
MX (1) MX2021014575A (es)
PE (1) PE20220767A1 (es)
SG (1) SG11202113167QA (es)
WO (1) WO2020243135A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116999A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives and their use in the treatment of hbv infection
WO2022116998A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives as hbv inhibitors
TW202237617A (zh) * 2020-12-02 2022-10-01 愛爾蘭商健生科學愛爾蘭無限公司 稠合雜環衍生物
CN117715909A (zh) 2021-06-02 2024-03-15 杨森科学爱尔兰无限公司 稠合杂环衍生物
US20240279227A1 (en) * 2021-06-02 2024-08-22 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives
WO2024114709A1 (en) * 2022-12-01 2024-06-06 Janssen Sciences Ireland Unlimited Company A crystal form of a fused heterocycle derivative compound
WO2024140851A1 (zh) * 2022-12-28 2024-07-04 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993174A1 (en) * 2014-09-08 2016-03-09 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Pyrazolopyridine derivatives and their use in therapy
WO2016109684A2 (en) * 2014-12-30 2016-07-07 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis b infections
US10975077B2 (en) * 2016-06-29 2021-04-13 Novira Therapeutics, Inc. Diazepinone derivatives and their use in the treatment of hepatitis B infections
US10987359B2 (en) * 2016-06-29 2021-04-27 Novira Therapeutics, Inc. Oxadiazepinone derivatives and methods of treating hepatitis B infections

Also Published As

Publication number Publication date
BR112021022889A2 (pt) 2022-01-04
WO2020243135A1 (en) 2020-12-03
CO2021016433A2 (es) 2021-12-10
AU2020285718A1 (en) 2022-02-03
CL2021003155A1 (es) 2022-07-22
KR20220012913A (ko) 2022-02-04
CR20210666A (es) 2022-03-11
MX2021014575A (es) 2022-05-24
BR112021022889A8 (pt) 2024-03-05
IL288322A (en) 2022-01-01
CA3138168A1 (en) 2020-12-03
CN113906028A (zh) 2022-01-07
JP2022535734A (ja) 2022-08-10
SG11202113167QA (en) 2021-12-30
EP3976617A1 (en) 2022-04-06
MA56043A (fr) 2022-04-06
JOP20210313A1 (ar) 2023-01-30

Similar Documents

Publication Publication Date Title
PE20220767A1 (es) Derivados heterociclicos condensados
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
CL2017001426A1 (es) Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales.
CL2017001798A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas.
DOP2019000117A (es) Nuevos derivados de quinolina
SV2018005610A (es) Derivados de oxopiridina sustituidos
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
BR112017000550A2 (pt) compostos antiproliferativos e métodos de uso dos mesmos
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
UY37645A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
CO2018008421A2 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
UY37831A (es) Nuevos derivados de quinolina
UY37182A (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue
CL2015002529A1 (es) Compuestos de tetrahidropirrolotiazina
BR112018072168A2 (pt) compostos derivados da pirimidina como inibidores da quinase jak
UY37646A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
UY37741A (es) Derivados de indolina sustituidos como inhibidores de la replicación del virus del dengue
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CL2021000514A1 (es) Dimetilaminoazetidinaminas como inhibidores de jak
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
UY37742A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
CL2020002891A1 (es) Nuevos derivados de quinolina